Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier to get Screeners that run automatically with the results emailed to you! FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Centessa Pharmaceuticals Plc ADR (CNTA)

Centessa Pharmaceuticals Plc ADR (CNTA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Centessa Pharmaceuticals Plc ADR 3rd Floor 1 Ashley Road Altrincham Cheshire X0 WA14 2DT GBR

www.centessa.com Employees: 77 P: 617-468-5770

Sector:

Medical

Description:

Centessa Pharmaceuticals plc is a clinical-stage company employing its innovative asset-centric business model to discover, develop and ultimately deliver impactful medicines to patients. Centessa Pharmaceuticals plc is based in Cambridge, United Kingdom.

Key Statistics

Overview:

Market Capitalization, $K 1,873,777
Enterprise Value, $K 1,599,497
Shares Outstanding, K 133,555
Annual Sales, $ 0 K
Annual Net Income, $ -235,760 K
Last Quarter Sales, $ 15,000 K
Last Quarter Net Income, $ -26,140 K
EBIT, $ -195,750 K
EBITDA, $ -194,810 K
60-Month Beta 1.45
% of Insider Shareholders 7.09%
% of Institutional Shareholders 82.01%
Float, K 124,086
% Float 92.91%
Short Volume Ratio 0.35

Growth:

1-Year Return 47.98%
3-Year Return 169.29%
5-Year Return 0.00%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth 0.00%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.20 on 05/14/25
Next Earnings Date 08/12/25
Earnings Per Share ttm -1.31
EPS Growth vs. Prev Qtr 41.18%
EPS Growth vs. Prev Year 47.37%
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%

CNTA Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -40.22%
Return-on-Assets % -29.95%
Profit Margin % 0.00%
Debt/Equity 0.28
Price/Sales 114.82
Price/Cash Flow N/A
Price/Book 4.68
Book Value/Share 2.90
Interest Coverage -22.08
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar